#HaHa. Remember last month when Turing Pharmaceuticals CEO and founder Martin Shkreli stunned the world with his Mr Burns-level villainy by buying up the HIV/AIDS drug Daraprim and hiking the price 5,000% – from $13.50 per tablet to $750 per tablet? Well, what goes around comes around. It was announced today that Imprimis – a San Diego-based pharmaceutical company – will now sell a generic version of the drug for $1 per pill – effectively undercutting Shkreli’s dick move, and making his $55 million acquisition worthless.
From NBC News:
“While we respect Turing’s right to charge patients and insurance companies whatever it believes is appropriate, there may be more cost-effective compounded options for medications, such as Daraprim, for patients, physicians, insurance companies and pharmacy benefit managers to consider,” Imprimis CEO Mark Baum said in a statement.
“This is not the first time a sole supply generic drug — especially one that has been approved for use as long as Daraprim — has had its price increased suddenly and to a level that may make it unaffordable,” Baum said.
“In response to this recent case and others that we will soon identify, Imprimis is forming a new program called Imprimis Cares which is aligned to our corporate mission of making novel and customizable medicines available to physicians and patients today at accessible prices,” Baum said.